These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 16086600
1. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD. Saberi F, O'Donnell DE. Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600 [Abstract] [Full Text] [Related]
2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ, Keating GM. Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [Abstract] [Full Text] [Related]
6. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator]. Izquierdo Alonso JL. An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035 [Abstract] [Full Text] [Related]
7. Role of tiotropium in the treatment of COPD. Rice KL, Kunisaki KM, Niewoehner DE. Int J Chron Obstruct Pulmon Dis; 2007 Dec; 2(2):95-105. PubMed ID: 18044681 [Abstract] [Full Text] [Related]
8. Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? Tennant RC, Erin EM, Barnes PJ, Hansel TT. Curr Opin Pharmacol; 2003 Jun; 3(3):270-6. PubMed ID: 12810191 [Abstract] [Full Text] [Related]
11. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)]. Beeh KM, Welte T, Buhl R. Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472 [Abstract] [Full Text] [Related]
12. The role of long-acting bronchodilators in the management of stable COPD. Tashkin DP, Cooper CB. Chest; 2004 Jan; 125(1):249-59. PubMed ID: 14718448 [Abstract] [Full Text] [Related]
13. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. Panning CA, DeBisschop M. Pharmacotherapy; 2003 Feb; 23(2):183-9. PubMed ID: 12587807 [Abstract] [Full Text] [Related]
14. Anticholinergic agents in asthma and COPD. Gross NJ. Eur J Pharmacol; 2006 Mar 08; 533(1-3):36-9. PubMed ID: 16488410 [Abstract] [Full Text] [Related]
15. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Koumis T, Samuel S. Clin Ther; 2005 Apr 08; 27(4):377-92. PubMed ID: 15922812 [Abstract] [Full Text] [Related]
16. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence. Salpeter SR. Drugs; 2009 Oct 22; 69(15):2025-33. PubMed ID: 19791824 [Abstract] [Full Text] [Related]
17. Tiotropium bromide. Lipson DA. Int J Chron Obstruct Pulmon Dis; 2006 Oct 22; 1(2):107-14. PubMed ID: 18046887 [Abstract] [Full Text] [Related]
18. Tiotropium: a potential replacement for ipratropium in patients with COPD. Shukla VK. Issues Emerg Health Technol; 2002 Jul 22; (35):1-4. PubMed ID: 12195603 [Abstract] [Full Text] [Related]
19. Safety, tolerability and risk benefit analysis of tiotropium in COPD. Oba Y, Zaza T, Thameem DM. Int J Chron Obstruct Pulmon Dis; 2008 Jul 22; 3(4):575-84. PubMed ID: 19281075 [Abstract] [Full Text] [Related]
20. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Halpin DM, Kaplan AG, Russell RK. Respir Med; 2017 Jul 22; 128():28-41. PubMed ID: 28610667 [Abstract] [Full Text] [Related] Page: [Next] [New Search]